Skvarka Jan 4
4 · Zentalis Pharmaceuticals, Inc. · Filed Jun 18, 2025
Insider Transaction Report
Form 4
Skvarka Jan
Director
Transactions
- Award
Common Stock
2025-06-17+57,603→ 207,154 total
Footnotes (1)
- [F1]Represents restricted stock units granted pursuant to the Issuer's Non-Employee Director Compensation Program, each of which represents a contingent right to receive one share of common stock, and which will vest on the first to occur of (a) June 17, 2026 or (b) the next occurring annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service on the Issuer's Board of Directors through such vesting date.